RUNELON ALCUDIA: Open Payments
NPI 1518473370 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,940 in 51 payments from 16 companies in 2025. Trend: 2023 $1,460 · 2024 $1,700 · 2025 $1,940
Food & beverage: $1,940
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $404 |
| E.R. Squibb & Sons, L.L.C. | 11 | $276 |
| CVRx, Inc. | 2 | $178 |
| Medtronic, Inc. | 1 | $173 |
| BridgeBio Pharma, Inc. | 2 | $153 |
| Boston Scientific Corporation | 1 | $143 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Alnylam Pharmaceuticals Inc. | 4 | $98 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
Products named: CARDIOMEMS, Barostim Neo System, ONYX FRONTIER, Attruby, CAMZYOS, General - Vascular Intervention, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, ELIQUIS.
Industry payments across FL — which companies pay providers there.
